“Delinkage” Of Medicines R&D From Patent Incentives Stirs Debate at Human Rights Council 04/07/2019 Elaine Ruth Fletcher Only a month after a hotly-contested World Health Assembly resolution touched off a debate around “price transparency” as a way to improve access to medicines, a new controversy over how to stimulate access has emerged in another UN Forum, the Human Rights Council. This time the debate is around ways to “delink” incentives for the […] Continue reading -> Dr Tedros Calls For Investment In Nurses, Highlights WHA 2020 Focus On Nurses & Midwives 02/07/2019 David Branigan In a surprise appearance before the 2019 Congress of the International Council of Nurses, WHO Director-General Dr Tedros Adhanom Ghebreyesus said that investing in a stronger nursing workforce is essential for achieving universal health coverage (UHC). He proposed that “every country bring one nurse and one midwife to the World Health Assembly next year,” as […] Continue reading -> Selection Of New UNAIDS Executive Director Raises Larger Questions About Agency’s Purpose & Direction 26/06/2019 Elaine Ruth Fletcher & David Branigan A sensitive, closed-door selection of the new Executive Director for UNAIDS has kicked up a noisy social media debate among a number of leading global health figures, who questioned whether a separate bureaucracy for one disease, founded at the height of the AIDS epidemic, remains justified today – when bigger global health threats now loom. […] Continue reading -> WHO Launches Campaign to Combat Antimicrobial Resistance; Most Countries Fail to Report Aggregate Drug Use 18/06/2019 Elaine Ruth Fletcher The World Health Organization (WHO) today launched a global AWaRe campaign, which aims to support national health systems to make more judicious use of lifesaving drugs so as to combat a worldwide trend of antimicrobial resistance (AMR) – including increased pathogen resistance to common antibiotics, antivirals and anti-fungal medications. However, WHO’s own 2018 Report on […] Continue reading -> Major R&D Funding Needed To Reach 2030 Goal For Ending TB Epidemic 17/06/2019 Catherine Saez Nine months after a historic high-level UN meeting where countries pledged to end the global tuberculosis epidemic by 2030, a chronic lack of R&D financing jeopardises that ambitious goal, said expert panelists at a briefing on the TB R&D landscape last week in Geneva, hosted by South Africa’s Permanent Mission to the UN. While there […] Continue reading -> Draft UHC Declaration Strong On R&D Transparency, Weak On R&D Incentives Reform 14/06/2019 David Branigan In the lead-up to the United Nations High-Level Meeting on Universal Health Coverage (UHC) in September, the latest draft of a planned political declaration calls on member states to increase transparency of the cost of research and development (R&D) – in addition to drug prices – but falls short in the area of R&D incentive […] Continue reading -> New Resource Gateway Launched On Innovation & Access To Medicines 14/06/2019 Elaine Ruth Fletcher A new Knowledge Portal that aims to ease policymakers’ access to reliable information about themes in medicines access, pricing and pharma innovation was launched today by the Global Health Centre of Geneva’s Graduate Institute of International and Development Studies. The Portal currently covers some 17 topics grouped under three broad themes – Pricing, Intellectual Property […] Continue reading -> New Drug Transparency Observatory Launched In France 13/06/2019 David Branigan Following the adoption of the World Health Assembly resolution on the transparency of medicines markets last month, a new civil society group has formed in France to monitor the French government’s implementation of the resolution. L’Observatoire Transparence Médicaments (Drug Transparency Observatory), was launched today in a statement calling on the French government and all countries […] Continue reading -> Curable STI Rates Show No Sign Of Declining – Most People Infected Don’t Know 06/06/2019 David Branigan 1 in 25 people globally have at least one of the four major preventable and curable sexually transmitted infections (STIs) – chlamydia, gonorrhoea, trichomoniasis, and syphilis – but most people don’t know they are infected, leading to serious health consequences. Image Credits: Jonathan Torgovnik/WHO. Continue reading -> WHO’s EB Considers New Ways To Work With NGOs – Some Countries Criticise Activists’ Role At WHA 72 30/05/2019 Elaine Ruth Fletcher In the wake of a World Health Assembly that became a focus of intense activist and social media attention over a WHO resolution on medicines price transparency, member states are now looking at new rules for shaping involvement of NGOs and other “non-state actors” at public WHO meetings. Image Credits: WHO. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Dr Tedros Calls For Investment In Nurses, Highlights WHA 2020 Focus On Nurses & Midwives 02/07/2019 David Branigan In a surprise appearance before the 2019 Congress of the International Council of Nurses, WHO Director-General Dr Tedros Adhanom Ghebreyesus said that investing in a stronger nursing workforce is essential for achieving universal health coverage (UHC). He proposed that “every country bring one nurse and one midwife to the World Health Assembly next year,” as […] Continue reading -> Selection Of New UNAIDS Executive Director Raises Larger Questions About Agency’s Purpose & Direction 26/06/2019 Elaine Ruth Fletcher & David Branigan A sensitive, closed-door selection of the new Executive Director for UNAIDS has kicked up a noisy social media debate among a number of leading global health figures, who questioned whether a separate bureaucracy for one disease, founded at the height of the AIDS epidemic, remains justified today – when bigger global health threats now loom. […] Continue reading -> WHO Launches Campaign to Combat Antimicrobial Resistance; Most Countries Fail to Report Aggregate Drug Use 18/06/2019 Elaine Ruth Fletcher The World Health Organization (WHO) today launched a global AWaRe campaign, which aims to support national health systems to make more judicious use of lifesaving drugs so as to combat a worldwide trend of antimicrobial resistance (AMR) – including increased pathogen resistance to common antibiotics, antivirals and anti-fungal medications. However, WHO’s own 2018 Report on […] Continue reading -> Major R&D Funding Needed To Reach 2030 Goal For Ending TB Epidemic 17/06/2019 Catherine Saez Nine months after a historic high-level UN meeting where countries pledged to end the global tuberculosis epidemic by 2030, a chronic lack of R&D financing jeopardises that ambitious goal, said expert panelists at a briefing on the TB R&D landscape last week in Geneva, hosted by South Africa’s Permanent Mission to the UN. While there […] Continue reading -> Draft UHC Declaration Strong On R&D Transparency, Weak On R&D Incentives Reform 14/06/2019 David Branigan In the lead-up to the United Nations High-Level Meeting on Universal Health Coverage (UHC) in September, the latest draft of a planned political declaration calls on member states to increase transparency of the cost of research and development (R&D) – in addition to drug prices – but falls short in the area of R&D incentive […] Continue reading -> New Resource Gateway Launched On Innovation & Access To Medicines 14/06/2019 Elaine Ruth Fletcher A new Knowledge Portal that aims to ease policymakers’ access to reliable information about themes in medicines access, pricing and pharma innovation was launched today by the Global Health Centre of Geneva’s Graduate Institute of International and Development Studies. The Portal currently covers some 17 topics grouped under three broad themes – Pricing, Intellectual Property […] Continue reading -> New Drug Transparency Observatory Launched In France 13/06/2019 David Branigan Following the adoption of the World Health Assembly resolution on the transparency of medicines markets last month, a new civil society group has formed in France to monitor the French government’s implementation of the resolution. L’Observatoire Transparence Médicaments (Drug Transparency Observatory), was launched today in a statement calling on the French government and all countries […] Continue reading -> Curable STI Rates Show No Sign Of Declining – Most People Infected Don’t Know 06/06/2019 David Branigan 1 in 25 people globally have at least one of the four major preventable and curable sexually transmitted infections (STIs) – chlamydia, gonorrhoea, trichomoniasis, and syphilis – but most people don’t know they are infected, leading to serious health consequences. Image Credits: Jonathan Torgovnik/WHO. Continue reading -> WHO’s EB Considers New Ways To Work With NGOs – Some Countries Criticise Activists’ Role At WHA 72 30/05/2019 Elaine Ruth Fletcher In the wake of a World Health Assembly that became a focus of intense activist and social media attention over a WHO resolution on medicines price transparency, member states are now looking at new rules for shaping involvement of NGOs and other “non-state actors” at public WHO meetings. Image Credits: WHO. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Selection Of New UNAIDS Executive Director Raises Larger Questions About Agency’s Purpose & Direction 26/06/2019 Elaine Ruth Fletcher & David Branigan A sensitive, closed-door selection of the new Executive Director for UNAIDS has kicked up a noisy social media debate among a number of leading global health figures, who questioned whether a separate bureaucracy for one disease, founded at the height of the AIDS epidemic, remains justified today – when bigger global health threats now loom. […] Continue reading -> WHO Launches Campaign to Combat Antimicrobial Resistance; Most Countries Fail to Report Aggregate Drug Use 18/06/2019 Elaine Ruth Fletcher The World Health Organization (WHO) today launched a global AWaRe campaign, which aims to support national health systems to make more judicious use of lifesaving drugs so as to combat a worldwide trend of antimicrobial resistance (AMR) – including increased pathogen resistance to common antibiotics, antivirals and anti-fungal medications. However, WHO’s own 2018 Report on […] Continue reading -> Major R&D Funding Needed To Reach 2030 Goal For Ending TB Epidemic 17/06/2019 Catherine Saez Nine months after a historic high-level UN meeting where countries pledged to end the global tuberculosis epidemic by 2030, a chronic lack of R&D financing jeopardises that ambitious goal, said expert panelists at a briefing on the TB R&D landscape last week in Geneva, hosted by South Africa’s Permanent Mission to the UN. While there […] Continue reading -> Draft UHC Declaration Strong On R&D Transparency, Weak On R&D Incentives Reform 14/06/2019 David Branigan In the lead-up to the United Nations High-Level Meeting on Universal Health Coverage (UHC) in September, the latest draft of a planned political declaration calls on member states to increase transparency of the cost of research and development (R&D) – in addition to drug prices – but falls short in the area of R&D incentive […] Continue reading -> New Resource Gateway Launched On Innovation & Access To Medicines 14/06/2019 Elaine Ruth Fletcher A new Knowledge Portal that aims to ease policymakers’ access to reliable information about themes in medicines access, pricing and pharma innovation was launched today by the Global Health Centre of Geneva’s Graduate Institute of International and Development Studies. The Portal currently covers some 17 topics grouped under three broad themes – Pricing, Intellectual Property […] Continue reading -> New Drug Transparency Observatory Launched In France 13/06/2019 David Branigan Following the adoption of the World Health Assembly resolution on the transparency of medicines markets last month, a new civil society group has formed in France to monitor the French government’s implementation of the resolution. L’Observatoire Transparence Médicaments (Drug Transparency Observatory), was launched today in a statement calling on the French government and all countries […] Continue reading -> Curable STI Rates Show No Sign Of Declining – Most People Infected Don’t Know 06/06/2019 David Branigan 1 in 25 people globally have at least one of the four major preventable and curable sexually transmitted infections (STIs) – chlamydia, gonorrhoea, trichomoniasis, and syphilis – but most people don’t know they are infected, leading to serious health consequences. Image Credits: Jonathan Torgovnik/WHO. Continue reading -> WHO’s EB Considers New Ways To Work With NGOs – Some Countries Criticise Activists’ Role At WHA 72 30/05/2019 Elaine Ruth Fletcher In the wake of a World Health Assembly that became a focus of intense activist and social media attention over a WHO resolution on medicines price transparency, member states are now looking at new rules for shaping involvement of NGOs and other “non-state actors” at public WHO meetings. Image Credits: WHO. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Launches Campaign to Combat Antimicrobial Resistance; Most Countries Fail to Report Aggregate Drug Use 18/06/2019 Elaine Ruth Fletcher The World Health Organization (WHO) today launched a global AWaRe campaign, which aims to support national health systems to make more judicious use of lifesaving drugs so as to combat a worldwide trend of antimicrobial resistance (AMR) – including increased pathogen resistance to common antibiotics, antivirals and anti-fungal medications. However, WHO’s own 2018 Report on […] Continue reading -> Major R&D Funding Needed To Reach 2030 Goal For Ending TB Epidemic 17/06/2019 Catherine Saez Nine months after a historic high-level UN meeting where countries pledged to end the global tuberculosis epidemic by 2030, a chronic lack of R&D financing jeopardises that ambitious goal, said expert panelists at a briefing on the TB R&D landscape last week in Geneva, hosted by South Africa’s Permanent Mission to the UN. While there […] Continue reading -> Draft UHC Declaration Strong On R&D Transparency, Weak On R&D Incentives Reform 14/06/2019 David Branigan In the lead-up to the United Nations High-Level Meeting on Universal Health Coverage (UHC) in September, the latest draft of a planned political declaration calls on member states to increase transparency of the cost of research and development (R&D) – in addition to drug prices – but falls short in the area of R&D incentive […] Continue reading -> New Resource Gateway Launched On Innovation & Access To Medicines 14/06/2019 Elaine Ruth Fletcher A new Knowledge Portal that aims to ease policymakers’ access to reliable information about themes in medicines access, pricing and pharma innovation was launched today by the Global Health Centre of Geneva’s Graduate Institute of International and Development Studies. The Portal currently covers some 17 topics grouped under three broad themes – Pricing, Intellectual Property […] Continue reading -> New Drug Transparency Observatory Launched In France 13/06/2019 David Branigan Following the adoption of the World Health Assembly resolution on the transparency of medicines markets last month, a new civil society group has formed in France to monitor the French government’s implementation of the resolution. L’Observatoire Transparence Médicaments (Drug Transparency Observatory), was launched today in a statement calling on the French government and all countries […] Continue reading -> Curable STI Rates Show No Sign Of Declining – Most People Infected Don’t Know 06/06/2019 David Branigan 1 in 25 people globally have at least one of the four major preventable and curable sexually transmitted infections (STIs) – chlamydia, gonorrhoea, trichomoniasis, and syphilis – but most people don’t know they are infected, leading to serious health consequences. Image Credits: Jonathan Torgovnik/WHO. Continue reading -> WHO’s EB Considers New Ways To Work With NGOs – Some Countries Criticise Activists’ Role At WHA 72 30/05/2019 Elaine Ruth Fletcher In the wake of a World Health Assembly that became a focus of intense activist and social media attention over a WHO resolution on medicines price transparency, member states are now looking at new rules for shaping involvement of NGOs and other “non-state actors” at public WHO meetings. Image Credits: WHO. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Major R&D Funding Needed To Reach 2030 Goal For Ending TB Epidemic 17/06/2019 Catherine Saez Nine months after a historic high-level UN meeting where countries pledged to end the global tuberculosis epidemic by 2030, a chronic lack of R&D financing jeopardises that ambitious goal, said expert panelists at a briefing on the TB R&D landscape last week in Geneva, hosted by South Africa’s Permanent Mission to the UN. While there […] Continue reading -> Draft UHC Declaration Strong On R&D Transparency, Weak On R&D Incentives Reform 14/06/2019 David Branigan In the lead-up to the United Nations High-Level Meeting on Universal Health Coverage (UHC) in September, the latest draft of a planned political declaration calls on member states to increase transparency of the cost of research and development (R&D) – in addition to drug prices – but falls short in the area of R&D incentive […] Continue reading -> New Resource Gateway Launched On Innovation & Access To Medicines 14/06/2019 Elaine Ruth Fletcher A new Knowledge Portal that aims to ease policymakers’ access to reliable information about themes in medicines access, pricing and pharma innovation was launched today by the Global Health Centre of Geneva’s Graduate Institute of International and Development Studies. The Portal currently covers some 17 topics grouped under three broad themes – Pricing, Intellectual Property […] Continue reading -> New Drug Transparency Observatory Launched In France 13/06/2019 David Branigan Following the adoption of the World Health Assembly resolution on the transparency of medicines markets last month, a new civil society group has formed in France to monitor the French government’s implementation of the resolution. L’Observatoire Transparence Médicaments (Drug Transparency Observatory), was launched today in a statement calling on the French government and all countries […] Continue reading -> Curable STI Rates Show No Sign Of Declining – Most People Infected Don’t Know 06/06/2019 David Branigan 1 in 25 people globally have at least one of the four major preventable and curable sexually transmitted infections (STIs) – chlamydia, gonorrhoea, trichomoniasis, and syphilis – but most people don’t know they are infected, leading to serious health consequences. Image Credits: Jonathan Torgovnik/WHO. Continue reading -> WHO’s EB Considers New Ways To Work With NGOs – Some Countries Criticise Activists’ Role At WHA 72 30/05/2019 Elaine Ruth Fletcher In the wake of a World Health Assembly that became a focus of intense activist and social media attention over a WHO resolution on medicines price transparency, member states are now looking at new rules for shaping involvement of NGOs and other “non-state actors” at public WHO meetings. Image Credits: WHO. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Draft UHC Declaration Strong On R&D Transparency, Weak On R&D Incentives Reform 14/06/2019 David Branigan In the lead-up to the United Nations High-Level Meeting on Universal Health Coverage (UHC) in September, the latest draft of a planned political declaration calls on member states to increase transparency of the cost of research and development (R&D) – in addition to drug prices – but falls short in the area of R&D incentive […] Continue reading -> New Resource Gateway Launched On Innovation & Access To Medicines 14/06/2019 Elaine Ruth Fletcher A new Knowledge Portal that aims to ease policymakers’ access to reliable information about themes in medicines access, pricing and pharma innovation was launched today by the Global Health Centre of Geneva’s Graduate Institute of International and Development Studies. The Portal currently covers some 17 topics grouped under three broad themes – Pricing, Intellectual Property […] Continue reading -> New Drug Transparency Observatory Launched In France 13/06/2019 David Branigan Following the adoption of the World Health Assembly resolution on the transparency of medicines markets last month, a new civil society group has formed in France to monitor the French government’s implementation of the resolution. L’Observatoire Transparence Médicaments (Drug Transparency Observatory), was launched today in a statement calling on the French government and all countries […] Continue reading -> Curable STI Rates Show No Sign Of Declining – Most People Infected Don’t Know 06/06/2019 David Branigan 1 in 25 people globally have at least one of the four major preventable and curable sexually transmitted infections (STIs) – chlamydia, gonorrhoea, trichomoniasis, and syphilis – but most people don’t know they are infected, leading to serious health consequences. Image Credits: Jonathan Torgovnik/WHO. Continue reading -> WHO’s EB Considers New Ways To Work With NGOs – Some Countries Criticise Activists’ Role At WHA 72 30/05/2019 Elaine Ruth Fletcher In the wake of a World Health Assembly that became a focus of intense activist and social media attention over a WHO resolution on medicines price transparency, member states are now looking at new rules for shaping involvement of NGOs and other “non-state actors” at public WHO meetings. Image Credits: WHO. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Resource Gateway Launched On Innovation & Access To Medicines 14/06/2019 Elaine Ruth Fletcher A new Knowledge Portal that aims to ease policymakers’ access to reliable information about themes in medicines access, pricing and pharma innovation was launched today by the Global Health Centre of Geneva’s Graduate Institute of International and Development Studies. The Portal currently covers some 17 topics grouped under three broad themes – Pricing, Intellectual Property […] Continue reading -> New Drug Transparency Observatory Launched In France 13/06/2019 David Branigan Following the adoption of the World Health Assembly resolution on the transparency of medicines markets last month, a new civil society group has formed in France to monitor the French government’s implementation of the resolution. L’Observatoire Transparence Médicaments (Drug Transparency Observatory), was launched today in a statement calling on the French government and all countries […] Continue reading -> Curable STI Rates Show No Sign Of Declining – Most People Infected Don’t Know 06/06/2019 David Branigan 1 in 25 people globally have at least one of the four major preventable and curable sexually transmitted infections (STIs) – chlamydia, gonorrhoea, trichomoniasis, and syphilis – but most people don’t know they are infected, leading to serious health consequences. Image Credits: Jonathan Torgovnik/WHO. Continue reading -> WHO’s EB Considers New Ways To Work With NGOs – Some Countries Criticise Activists’ Role At WHA 72 30/05/2019 Elaine Ruth Fletcher In the wake of a World Health Assembly that became a focus of intense activist and social media attention over a WHO resolution on medicines price transparency, member states are now looking at new rules for shaping involvement of NGOs and other “non-state actors” at public WHO meetings. Image Credits: WHO. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Drug Transparency Observatory Launched In France 13/06/2019 David Branigan Following the adoption of the World Health Assembly resolution on the transparency of medicines markets last month, a new civil society group has formed in France to monitor the French government’s implementation of the resolution. L’Observatoire Transparence Médicaments (Drug Transparency Observatory), was launched today in a statement calling on the French government and all countries […] Continue reading -> Curable STI Rates Show No Sign Of Declining – Most People Infected Don’t Know 06/06/2019 David Branigan 1 in 25 people globally have at least one of the four major preventable and curable sexually transmitted infections (STIs) – chlamydia, gonorrhoea, trichomoniasis, and syphilis – but most people don’t know they are infected, leading to serious health consequences. Image Credits: Jonathan Torgovnik/WHO. Continue reading -> WHO’s EB Considers New Ways To Work With NGOs – Some Countries Criticise Activists’ Role At WHA 72 30/05/2019 Elaine Ruth Fletcher In the wake of a World Health Assembly that became a focus of intense activist and social media attention over a WHO resolution on medicines price transparency, member states are now looking at new rules for shaping involvement of NGOs and other “non-state actors” at public WHO meetings. Image Credits: WHO. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Curable STI Rates Show No Sign Of Declining – Most People Infected Don’t Know 06/06/2019 David Branigan 1 in 25 people globally have at least one of the four major preventable and curable sexually transmitted infections (STIs) – chlamydia, gonorrhoea, trichomoniasis, and syphilis – but most people don’t know they are infected, leading to serious health consequences. Image Credits: Jonathan Torgovnik/WHO. Continue reading -> WHO’s EB Considers New Ways To Work With NGOs – Some Countries Criticise Activists’ Role At WHA 72 30/05/2019 Elaine Ruth Fletcher In the wake of a World Health Assembly that became a focus of intense activist and social media attention over a WHO resolution on medicines price transparency, member states are now looking at new rules for shaping involvement of NGOs and other “non-state actors” at public WHO meetings. Image Credits: WHO. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO’s EB Considers New Ways To Work With NGOs – Some Countries Criticise Activists’ Role At WHA 72 30/05/2019 Elaine Ruth Fletcher In the wake of a World Health Assembly that became a focus of intense activist and social media attention over a WHO resolution on medicines price transparency, member states are now looking at new rules for shaping involvement of NGOs and other “non-state actors” at public WHO meetings. Image Credits: WHO. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy